Cargando…

Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect

Mycobacterium tuberculosis is one of the deadliest human pathogen of the tuberculosis diseases. Drug resistance leads to emergence of multidrug-resistant and extremely drug resistant strains of M. tuberculosis. Apart from principal targets of resistance, many explanations have been proposed for drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Divakar, Bisht, Deepa, Khan, Asad U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027512/ https://www.ncbi.nlm.nih.gov/pubmed/29843395 http://dx.doi.org/10.3390/proteomes6020026

Ejemplares similares

Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets
por: Sharma, Divakar, et al.
Publicado: (2015)

Role of Bacterioferritin & Ferritin in M. tuberculosis Pathogenesis and Drug Resistance: A Future Perspective by Interactomic Approach
por: Sharma, Divakar, et al.
Publicado: (2017)

M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance
por: Sharma, Divakar, et al.
Publicado: (2017)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

Culture filtrate proteome analysis of aminoglycoside resistant clinical isolates of Mycobacterium tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2014)

Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS
por: Sharma, Divakar, et al.
Publicado: (2016)

Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
por: Singh, Amit, et al.
Publicado: (2015)

Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis
por: Sharma, Prashant, et al.
Publicado: (2010)

Functional Characterization of PknI-Rv2159c Interaction in Redox Homeostasis of Mycobacterium tuberculosis
por: Venkatesan, Arunkumar, et al.
Publicado: (2016)

Down-Regulation of Flagellar, Fimbriae, and Pili Proteins in Carbapenem-Resistant Klebsiella pneumoniae (NDM-4) Clinical Isolates: A Novel Linkage to Drug Resistance
por: Sharma, Divakar, et al.
Publicado: (2019)

Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met
por: Gupta, Vivek Kumar, et al.
Publicado: (2017)

Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria
por: Khan, Asad U., et al.
Publicado: (2017)

Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities
por: Sharma, Sandeep, et al.
Publicado: (2022)

Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis
por: Swain, Shasank S., et al.
Publicado: (2020)

Antibiotics versus biofilm: an emerging battleground in microbial communities
por: Sharma, Divakar, et al.
Publicado: (2019)

Insights into Mycobacterium leprae Proteomics and Biomarkers—An Overview
por: Gautam, Sakshi, et al.
Publicado: (2021)

Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis
por: Allué-Guardia, Anna, et al.
Publicado: (2021)

Colistin Resistance and Management of Drug Resistant Infections
por: Sharma, Juhi, et al.
Publicado: (2022)

Multi-epitope vaccine against drug-resistant strains of Mycobacterium tuberculosis: a proteome-wide subtraction and immunoinformatics approach
por: Khan, Md Tahsin, et al.
Publicado: (2023)

Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates
por: Singhal, Neelja, et al.
Publicado: (2012)

Proteomic Characterization and Target Identification Against Streptococcus mutans Under Bacitracin Stress Conditions Using LC–MS and Subtractive Proteomics
por: Zaidi, Sahar, et al.
Publicado: (2022)

Nanoparticle Delivery of Anti-Tuberculosis Chemotherapy as a Potential Mediator Against Drug-Resistant Tuberculosis
por: Smith, Jonathan Paul
Publicado: (2011)

Strategies to Combat Multi-Drug Resistance in Tuberculosis
por: Singh, Vinayak, et al.
Publicado: (2021)

In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis
por: Marquês, Joaquim Trigo, et al.
Publicado: (2022)

Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes
por: Rudramurthy, Gudepalya Renukaiah, et al.
Publicado: (2016)

Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study
por: Becerra, Mercedes C, et al.
Publicado: (2019)

Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
por: Akbar, Zarka, et al.
Publicado: (2021)

Editorial: Alternative approaches to antifungal drugs against drug-resistant fungi
por: Kovács, Renátó, et al.
Publicado: (2023)

Proteome-Wide Screening of Potential Vaccine Targets against Brucella melitensis
por: Malik, Mahnoor, et al.
Publicado: (2023)

Potential of Selected African Medicinal Plants as Alternative Therapeutics against Multi-Drug-Resistant Bacteria
por: Moiketsi, Bertha N., et al.
Publicado: (2023)

Proteo-Molecular Investigation of Cultivated Rice, Wild Rice, and Barley Provides Clues of Defense Responses against Rhizoctonia solani Infection
por: Shamim, Md., et al.
Publicado: (2022)

Activity of Trifluoperazine against Replicating, Non-Replicating and Drug Resistant M. tuberculosis
por: Advani, Meeta J., et al.
Publicado: (2012)

BFluenza: A Proteomic Database on Bird Flu
por: Salahuddin, Parveen, et al.
Publicado: (2011)

Coupling of radiofrequency with magnetic nanoparticles treatment as an alternative physical antibacterial strategy against multiple drug resistant bacteria
por: Chaurasia, Akhilesh K., et al.
Publicado: (2016)

Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis
por: Xu, Jian, et al.
Publicado: (2023)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis
por: Lun, Shichun, et al.
Publicado: (2013)

Repurposing drug molecule against SARS-Cov-2 (COVID-19) through molecular docking and dynamics: a quick approach to pick FDA-approved drugs
por: Farhat, Nabeela, et al.
Publicado: (2021)

Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test
por: Gokarn, Karuna, et al.
Publicado: (2017)

Bacteriophage Proteome: Insights and Potentials of an Alternate to Antibiotics
por: Aslam, Bilal, et al.
Publicado: (2021)

Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis
por: Bunalema, Lydia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t6t50gtk8ils2d14vie94qtrr4